US 12350262
Methods of treatment for cystic fibrosis
granted A61KA61K31/404A61K31/443
Quick answer
US patent 12350262 (Methods of treatment for cystic fibrosis) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/404, A61K31/443, A61K31/4439, A61K31/47